Skip to main content
. 2015 Nov 17;59:266–274. doi: 10.1007/s00125-015-3795-1

Fig. 1.

Fig. 1

Patient disposition throughout the study. The study was ongoing at the time of data analysis and the number of patients who withdrew because of an adverse event by week 52 was reconciled to include two additional patients in each of the albiglutide treatment groups